Therefore, even in the background of methylated O6-methylguanine-DNA methyl-transferase (MGMT) promoter—a favorable prognostic factor in glioblastoma—the 5-year survival rate of glioblastoma is less than 5% [6]. Here, MGMT is linked to glioblastoma.